论文信息 - Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma - 字舞流文

Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma

V. Ferrari | A. Berruti | L. Canu | M. Terzolo | R. Ambrosini | M. Zamparini | S. Sigala | A. Abate | D. Cosentini | G. Tiberio | M. Laganà | A. Turla | S. Grisanti | A. Gianoncelli